“…FGF2 and FGF7, the high-affinity ligands for FGFR1-IIIc and FGFR2-IIIb, respectively, are each thought not to activate the other receptor. Effective doses for FGF2 and FGF7 are described as 100-250 ng/ml and <1000 ng/ml, respectively, in the manufacture's protocol, other published FGF studies have used a wide range of concentrations for these ligands, from 1-1000 ng/ml (Resnick et al, 1998;Weksler et al, 1999;Bridges et al, 2003;Kawase et al, 2004). Because FGF ligand-receptor interactions are influenced by many factors other than ligand concentration, such as heparin and cell-surface proteoglycans, it is impossible to determine what ligand concentrations in vitro will mimic physiological conditions.…”